|
1
|
Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J,
Shan Z, Liu J, Tian H and Ji Q: China National Diabetes and
Metabolic Disorders Study Group: Prevalence of diabetes among men
and women in China. N Engl J Med. 362:1090–1101. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu Y, Wang L, He J, Bi Y, Li M, Wang T,
Wang L, Jiang Y, Dai M, Lu J, et al: 2010 China Noncommunicable
Disease Surveillance Group: Prevalence and control of diabetes in
Chinese adults. JAMA. 310:948–959. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chinese medical association diabetes
society: Chinese type 2 diabetes prevention guide (2010). Zhong Guo
Tang Niao Bing Za Zhi She. 20:S1–S36. 2012.(In Chinese).
|
|
4
|
Lachin JM, Orchard TJ and Nathan DM:
DCCT/EDIC Research Group: Update on cardiovascular outcomes at 30
years of the Diabetes Control and Complications Trial/Epidemiology
of Diabetes Interventions and Complications study. Diabetes Care.
37:39–43. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Martin CL, Albers JW and Pop-Busui R:
DCCT/EDIC Research Group: Neuropathy and related findings in the
Diabetes Control and Complications Trial/Epidemiology of Diabetes
Interventions and Complications study. Diabetes Care. 37:31–38.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Holman RR, Paul SK, Bethel MA, Matthews DR
and Neil HA: 10-year follow-up of intensive glucose control in type
2 diabetes. N Engl J Med. 359:1577–1589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nathan DM, Cleary PA, Backlund JY, Genuth
SM, Lachin JM, Orchard TJ, Raskin P and Zinman B: Diabetes Control
and Complications Trial/Epidemiology of Diabetes Interventions and
Complications (DCCT/EDIC) Study Research Group: Intensive diabetes
treatment and cardiovascular disease in patients with type 1
diabetes. N Engl J Med. 353:2643–2653. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
UK Prospective Diabetes Study (UKPDS)
Group: Intensive blood-glucose control with sulphonylureas or
insulin compared with conventional treatment and risk of
complications in patients with type 2 diabetes (UKPDS 33). Lancet.
352:837–853. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cryer PE, Axelrod L, Grossman AB, Heller
SR and Montori VM: Seaquist ER and Service FJ; Endocrine Society:
Evaluation and management of adult hypoglycemic disorders: An
Endocrine Society Clinical Practice Guideline. J Clin Endocrinol
Metab. 94:709–728. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nathan DM, McGee P, Steffes MW and Lachin
JM: DCCT/EDIC Research Group: Relationship of glycated albumin to
blood glucose and HbA1c values and to retinopathy, nephropathy and
cardiovascular outcomes in the DCCT/EDIC study. Diabetes.
63:282–290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
TODAY Study Group: Retinopathy in youth
with type 2 diabetes participating in the TODAY clinical trial.
Diabetes Care. 36:1772–1774. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bai R, Li L, Yao JJ, Shi SH, Liu Y, Lu Y,
Du JL and Ll CC: Damage to the cultured rat mesangial cells by
constant and intermittent high glucose. Zhonghua Nei Fen Mi Dai Xie
Za Zhi. 26:1063–1066. 2010.(In Chinese).
|
|
13
|
Di Flaviani A, Picconi F, Di Stefano P,
Giordani I, Malandrucco I, Maggio P, Palazzo P, Sgreccia F, Peraldo
C, Farina F, et al: Impact of glycemic and blood pressure
variability on surrogate measures of cardiovascular outcomes in
type 2 diabetic patients. Diabetes Care. 34:1605–1609. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Su G, Mi S, Tao H, Li Z, Yang H, Zheng H,
Zhou Y and Ma C: Association of glycemic variability and the
presence and severity of coronary artery disease in patients with
type 2 diabetes. Cardiovasc Diabetol. 10:192011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mo Y, Zhou J, Li M, Wang Y, Bao Y, Ma X,
Li D, Lu W, Hu C, Li M and Jia W: Glycemic variability is
associated with subclinical atherosclerosis in Chinese type 2
diabetic patients. Cardiovasc Diabetol. 12:152013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Grossmann V, Schmitt VH, Zeller T,
Panova-Noeva M, Schulz A, Laubert-Reh D, Juenger C, Schnabel RB,
Abt TG, Laskowski R, et al: Profile of the immune and inflammatory
response in individuals with prediabetes and type 2 diabetes.
Diabetes Care. 38:1356–1364. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
de Vries J, Thijssen WA, Snels SE,
Menovsky T, Peer NG and Lamers KJ: Intraoperative values of 100
protein, myelin basle protein, laetate and albumin in the CSF and
serum of neuroeurgical patients. J Neurol Neurosurg Psychiatry.
71:671–674. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Misra DP, Das S and Sahu PK: Prevalence of
inflammatory markers (high-sensitivity C-reactive protein, nuclear
factor-κB and adiponectin) in Indian patients with type 2 diabetes
mellitus with and without macrovascular complications. Metab Syndr
Relat Disord. 10:209–213. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Asegaonkar SB, Marathe A, Tekade ML,
Cherekar L, Bavikar J, Bardapurkar J and Ajay R: High-sensitivity
C-reactive protein: A novel cardiovascular risk predictor in type 2
diabetics with normal lipid profile. J Diabetes Complications.
25:368–370. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chinese Diabetes Society: China glucose
monitoring clinical application guide (2011 edition). Zhong Guo
Tang Niao Bing Za Zhi She. 91:656–664. 2011.(In Chinese).
|
|
21
|
Meng J, Ge J, Yu C, Xu L and Gu Q: The
analysis of dynamic glucose characteristics in type 2 diabetic
patients with different concentration of HbA1c. Zhongguo Tang Niao
Bing Za Zhi. 19:816–818. 2011.(In Chinese).
|
|
22
|
Sarinnapakorn V and Wanicagool W:
Association between hs-CRP and HbA1c in overweight type 2 diabetic
female patients. J Med Assoc Thai. 96(Suppl 3): S54–S58.
2013.PubMed/NCBI
|
|
23
|
Kilpatrick ES, Rigby AS and Atkin SL:
Effect of glucose variability on the long-term risk of
microvascular complications in type 1 diabetes. Diabetes Care.
32:1901–1903. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sakurai M, Saitoh S, Miura K, Nakagawa H,
Ohnishi H, Akasaka H, Kadota A, Kita Y, Hayakawa T, Ohkubo T, et
al: HbA1c and the risks for all-cause and cardiovascular mortality
in the general Japanese population: NIPPON DATA90. Diabetes Care.
36:3759–3765. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sartore G, Chilelli NC, Burlina S and
Lapolla A: Association between glucose variability as assessed by
continuous glucose monitoring (CGM) and diabetic retinopathy in
type 1 and type 2 diabetes. Acta Diabetol. 50:437–442. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Monnier L, Mas E, Ginet C, Michel F,
Villon L, Cristol JP and Colette C: Activation of oxidative stress
by acute glucose fluctuations compared with sustained chronic
hyperglycemia in patients with type 2 diabetes. JAMA.
295:1681–1687. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chang CM, Hsieh CJ, Huang JC and Huang IC:
Acute and chronic fluctuations in blood glucose levels can increase
oxidative stress in type 2 diabetes mellitus. Acta Diabetol.
49(Suppl 1): S171–S177. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang X, Xu X, Jiao X, Wu J, Zhou S and Lv
X: The effects of glucose fluctuation on the severity of coronary
artery disease in type 2 diabetes mellitus. J Diabetes Res.
2013:5769162013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rizzo MR, Barbieri M, Marfella R and
Paolisso G: Reduction of oxidative stress and inflammation by
blunting daily acute glucose fluctuations in patients with type 2
diabetes: Role of dipeptidyl peptidase-IV inhibition. Diabetes
Care. 35:2076–2082. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schnell O, Amann-Zalan I, Jelsovsky Z,
Moritz A, Bermejo JL, Parkin CG, Schweitzer MA, Fisher L and
Polonsky WH: Changes in A1C levels are significantly associated
with changes in levels of the cardiovascular risk biomarker hs-CRP:
Results from the Step study. Diabetes Care. 36:2084–2089. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang Y, Du JL, Zhang XJ, Bai R, Ba Y, Xing
Q, Sun LP, Sun GH and Li CC: Association between serum amyloid A
and intima-media thickness of common carotid artery in patients
with type 2 diabetes. Zhonghua Nei Fen Mi Dai Xie Za Zhi.
24:188–189. 2008.(In Chinese).
|
